FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2904259315> ?p ?o ?g. }

• W2904259315 endingPage "250" @default.
• W2904259315 startingPage "239" @default.
• W2904259315 abstract "Most hepatocellular carcinomas (HCCs) arise in the context of chronic liver disease and/or cirrhosis. Thus, chemoprevention in individuals at risk represents an important but yet unproven approach. In this study, we investigated the ability of microRNA (miRNA)-based molecules to prevent liver cancer development in a cirrhotic model. To this end, we developed a mouse model able to recapitulate the natural progression from fibrosis to HCC, and then we tested the prophylactic activity of an miRNA-based approach in the model. The experiments were carried out in the TG221 transgenic mouse, characterized by the overexpression of miR-221 in the liver and predisposed to the development of liver tumors. TG221 as well as wild-type mice were exposed to the hepatotoxin carbon tetrachloride (CCl4) to induce chronic liver damage. All mice developed liver cirrhosis, but only TG221 mice developed nodular lesions in 100% of cases within 6 months of age. The spectrum of lesions ranged from dysplastic foci to carcinomas. To investigate miRNA-based prophylactic approaches, anti-miR-221 oligonucleotides or miR-199a-3p mimics were administered to TG221 CCl4-treated mice. Compared to control animals, a significant reduction in number, size, and, most significantly, malignant phenotype of liver nodules was observed, thus demonstrating an important prophylactic action of miRNA-based molecules. In summary, in this article, we not only report a simple model of liver cancer in a cirrhotic background but also provide evidence for a potential miRNA-based approach to reduce the risk of HCC development. Most hepatocellular carcinomas (HCCs) arise in the context of chronic liver disease and/or cirrhosis. Thus, chemoprevention in individuals at risk represents an important but yet unproven approach. In this study, we investigated the ability of microRNA (miRNA)-based molecules to prevent liver cancer development in a cirrhotic model. To this end, we developed a mouse model able to recapitulate the natural progression from fibrosis to HCC, and then we tested the prophylactic activity of an miRNA-based approach in the model. The experiments were carried out in the TG221 transgenic mouse, characterized by the overexpression of miR-221 in the liver and predisposed to the development of liver tumors. TG221 as well as wild-type mice were exposed to the hepatotoxin carbon tetrachloride (CCl4) to induce chronic liver damage. All mice developed liver cirrhosis, but only TG221 mice developed nodular lesions in 100% of cases within 6 months of age. The spectrum of lesions ranged from dysplastic foci to carcinomas. To investigate miRNA-based prophylactic approaches, anti-miR-221 oligonucleotides or miR-199a-3p mimics were administered to TG221 CCl4-treated mice. Compared to control animals, a significant reduction in number, size, and, most significantly, malignant phenotype of liver nodules was observed, thus demonstrating an important prophylactic action of miRNA-based molecules. In summary, in this article, we not only report a simple model of liver cancer in a cirrhotic background but also provide evidence for a potential miRNA-based approach to reduce the risk of HCC development." @default.
• W2904259315 created "2018-12-22" @default.
• W2904259315 creator A5001240587 @default.
• W2904259315 creator A5002313919 @default.
• W2904259315 creator A5004507388 @default.
• W2904259315 creator A5008504942 @default.
• W2904259315 creator A5010513377 @default.
• W2904259315 creator A5012439159 @default.
• W2904259315 creator A5013178566 @default.
• W2904259315 creator A5023933781 @default.
• W2904259315 creator A5028264599 @default.
• W2904259315 creator A5032250906 @default.
• W2904259315 creator A5062519808 @default.
• W2904259315 creator A5068214836 @default.
• W2904259315 creator A5072614220 @default.
• W2904259315 creator A5076619850 @default.
• W2904259315 creator A5085011734 @default.
• W2904259315 creator A5086182688 @default.
• W2904259315 creator A5087506952 @default.
• W2904259315 creator A5090658922 @default.
• W2904259315 date "2019-03-01" @default.
• W2904259315 modified "2023-10-18" @default.
• W2904259315 title "MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer" @default.
• W2904259315 cites W1534515820 @default.
• W2904259315 cites W1757407923 @default.
• W2904259315 cites W185337159 @default.
• W2904259315 cites W1905968574 @default.
• W2904259315 cites W1971837077 @default.
• W2904259315 cites W1973285529 @default.
• W2904259315 cites W1975321401 @default.
• W2904259315 cites W1976801200 @default.
• W2904259315 cites W1982417449 @default.
• W2904259315 cites W1983734516 @default.
• W2904259315 cites W1987851658 @default.
• W2904259315 cites W1987944428 @default.
• W2904259315 cites W1989647054 @default.
• W2904259315 cites W1996222881 @default.
• W2904259315 cites W2000961142 @default.
• W2904259315 cites W2001769314 @default.
• W2904259315 cites W2006777514 @default.
• W2904259315 cites W2015018301 @default.
• W2904259315 cites W2020114264 @default.
• W2904259315 cites W2021666697 @default.
• W2904259315 cites W2023568503 @default.
• W2904259315 cites W2025452473 @default.
• W2904259315 cites W2030363002 @default.
• W2904259315 cites W2035008060 @default.
• W2904259315 cites W2036169252 @default.
• W2904259315 cites W2060459012 @default.
• W2904259315 cites W2067766028 @default.
• W2904259315 cites W2069072470 @default.
• W2904259315 cites W2069834798 @default.
• W2904259315 cites W2073195217 @default.
• W2904259315 cites W2073666494 @default.
• W2904259315 cites W2073682408 @default.
• W2904259315 cites W2075214027 @default.
• W2904259315 cites W2091205462 @default.
• W2904259315 cites W2093073599 @default.
• W2904259315 cites W2116865990 @default.
• W2904259315 cites W2123546830 @default.
• W2904259315 cites W2124347139 @default.
• W2904259315 cites W2128245420 @default.
• W2904259315 cites W2136795008 @default.
• W2904259315 cites W2137382137 @default.
• W2904259315 cites W2140116051 @default.
• W2904259315 cites W2141289353 @default.
• W2904259315 cites W2141956267 @default.
• W2904259315 cites W2145720555 @default.
• W2904259315 cites W2147934487 @default.
• W2904259315 cites W2151291779 @default.
• W2904259315 cites W2153657879 @default.
• W2904259315 cites W2154239359 @default.
• W2904259315 cites W2158378236 @default.
• W2904259315 cites W2163403599 @default.
• W2904259315 cites W2163427879 @default.
• W2904259315 cites W2163724251 @default.
• W2904259315 cites W2168825275 @default.
• W2904259315 cites W2170097870 @default.
• W2904259315 cites W2170331810 @default.
• W2904259315 cites W2171881938 @default.
• W2904259315 cites W2186419161 @default.
• W2904259315 cites W2273348573 @default.
• W2904259315 cites W2284522937 @default.
• W2904259315 cites W2462162283 @default.
• W2904259315 cites W2470830411 @default.
• W2904259315 cites W2490891607 @default.
• W2904259315 cites W2512360639 @default.
• W2904259315 cites W2525980773 @default.
• W2904259315 cites W2555602737 @default.
• W2904259315 cites W2559861346 @default.
• W2904259315 cites W2562685286 @default.
• W2904259315 cites W2574465504 @default.
• W2904259315 cites W2577850892 @default.
• W2904259315 cites W2593899782 @default.
• W2904259315 cites W2602981376 @default.
• W2904259315 cites W2607229053 @default.
• W2904259315 cites W2736520162 @default.
• W2904259315 cites W2736546300 @default.

• next